Trust
It's the ground we stand on, and it starts with listening
To us, innovation means a better quality of life for our patients
We build on our Galen legacy to harness the advances in science and technology and improve the daily lives of our metabolic disease community. Patient First Innovation is the promise that inspires us to act, guides our decisions and is a promise that we renew every day.
For rare metabolic disorders such as Phenylketonuria (PKU) and Tyrosinaemia (TYR)
Explore our full range or order a sample. As part of the Galsana community, we will take the time to understand your needs and provide the support you can rely on.